Shorla Oncology Stock
Shorla Oncology develops and commercializes specialty oncology drugs with a focus on rare, orphan, and pediatric cancers. It repurposes existing treatments to address critical drug shortages and improve patient outcomes. The company prioritizes accessibility and innovation in oncology care by reformulating proven therapies for better efficacy and administration.
For more Shorla Oncology stock information, or to buy or sell private shares, sign up for a MicroVentures account.
Management Team
| Sharon Cunningham Co-Founder and Chief Executive Officer |
| Orlaith Ryan Co-Founder and Chief Technology Officer |
| Rayna Herman Chief Commercial Officer |
